Literature DB >> 18848759

Acute painful neuropathy induced by rapid correction of serum glucose levels in diabetic patients.

Ron Dabby1, Menachem Sadeh, Yair Lampl, Ronit Gilad, Nathan Watemberg.   

Abstract

We report on acute painful neuropathy following reduction of high serum glucose levels in six diabetic patients, aged 27-52 (5 males). Initial glucose levels ranging between 270 and 600 mg/dL decreased to 60-160 mg/dL following insulin, pharmacologic or dietary treatment. Four patients had long-standing untreated diabetes (3-5 years). All six patients experienced severe excruciating neuropathic pain 2-4 weeks after initiation of treatment. Pain was generalized in all, starting in the feet in 4 cases. Pain intensity prompted the use of combination therapy with various anti-neuropathic pain agents. Symptoms gradually improved in all patients, allowing discontinuation of symptomatic therapy within 3-8 months. We conclude that acute painful neuropathy can complicate the correction of high glucose levels in diabetic patients. Therefore, careful correction of glucose levels should be considered in patients with long-standing uncontrolled diabetes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18848759     DOI: 10.1016/j.biopha.2008.08.011

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  11 in total

1.  Treatment-induced neuropathy of diabetes: an acute, iatrogenic complication of diabetes.

Authors:  Christopher H Gibbons; Roy Freeman
Journal:  Brain       Date:  2014-11-11       Impact factor: 13.501

2.  Treatment-induced diabetic neuropathy: a reversible painful autonomic neuropathy.

Authors:  Christopher H Gibbons; Roy Freeman
Journal:  Ann Neurol       Date:  2010-04       Impact factor: 10.422

3.  Abdominal Pain and Weight Loss in New-Onset Type 1 Diabetes.

Authors:  Amir Aslam; Joanne Byrne; Satyan M Rajbhandari
Journal:  Clin Diabetes       Date:  2014-01

Review 4.  Diabetic neuropathy: mechanisms, emerging treatments, and subtypes.

Authors:  James W Albers; Rodica Pop-Busui
Journal:  Curr Neurol Neurosci Rep       Date:  2014-08       Impact factor: 5.081

5.  Murine model and mechanisms of treatment-induced painful diabetic neuropathy.

Authors:  Juliet M Nicodemus; Cynthia Enriquez; Alexandra Marquez; Carlos J Anaya; Corinne G Jolivalt
Journal:  Neuroscience       Date:  2017-05-03       Impact factor: 3.590

Review 6.  Microvascular Complications Associated With Rapid Improvements in Glycemic Control in Diabetes.

Authors:  Christopher H Gibbons; Ann Goebel-Fabbri
Journal:  Curr Diab Rep       Date:  2017-07       Impact factor: 4.810

Review 7.  Treatment-Induced Neuropathy of Diabetes.

Authors:  Christopher H Gibbons
Journal:  Curr Diab Rep       Date:  2017-10-24       Impact factor: 4.810

Review 8.  [Diabetic neuropathy: do not only consider distal symmetrical neuropathy].

Authors:  K Doppler; K Reiners
Journal:  Nervenarzt       Date:  2015-02       Impact factor: 1.214

9.  Update on the management of diabetic polyneuropathies.

Authors:  Jayadave Shakher; Martin J Stevens
Journal:  Diabetes Metab Syndr Obes       Date:  2011-07-21       Impact factor: 3.168

10.  Acute diabetic neuropathy following improved glycaemic control: a case series and review.

Authors:  N Siddique; R Durcan; S Smyth; T Kyaw Tun; S Sreenan; J H McDermott
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2020-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.